Clinical Trials Directory

Trials / Completed

CompletedNCT03586505

Tolerance to Light for Patients Suffering From Keratitis

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
30 (actual)
Sponsor
Centre Hospitalier Universitaire de Saint Etienne · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

In order to develop an innovative device to study infectious keratitis, we need to illuminate the cornea of patients suffering from an infectious keratitis with red or near-infrared light. Because of technical reasons the shortest possible wavelength (red) presents advantages.

Detailed description

The aim of this preliminary study is to measure the maximal intensity tolerated during illumination with 6 wavelength corresponding : 2 red, 2 far red and 1 near infrared lights in order to determine the shortest wavelength well tolerated by patients, in comparison with the standard blue light illumination.

Conditions

Interventions

TypeNameDescription
DEVICELight exposureThe 6 lights used randomly are : * 482nm =standard blue light illumination, * 650nm, * 675nm, * 700nm, * 750nm * 800nm

Timeline

Start date
2018-07-03
Primary completion
2019-08-07
Completion
2019-08-07
First posted
2018-07-13
Last updated
2019-09-17

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT03586505. Inclusion in this directory is not an endorsement.

Tolerance to Light for Patients Suffering From Keratitis (NCT03586505) · Clinical Trials Directory